The global human papillomavirus (HPV) testing market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of HPV-related cancers and rising awareness about HPV infection among people. The increasing prevalence of HPV infection in women is also driving the growth of this market.
The global human papillomavirus (HPV) testing market has been segmented on the basis of type, application, and region. On the basis of type, it has been segmented into pap smear test and HPV DNA test. On the basis of application, it has been segmented into diagnostic centers, hospitals, clinics; while on the basis of region it has been segmented into North America, Latin America, Europe Asia Pacific and Middle East & Africa regions respectively.
Some Of The Growth Factors Of This Market:
- The HPV vaccine is available for both males and females, which has led to a decrease in the number of cases of cervical cancer.
- The HPV vaccine is recommended for all children between the ages of 11 and 12 years old, which has led to an increase in the number of people getting vaccinated against HPV.
- There are more than 100 types of human papillomavirus (HPV) that can infect humans, but only about 40 types are linked with cancer or genital warts.
- In 2016, there were over 14 million new cases of sexually transmitted infections (STIs) reported in the United States alone.
- In 2017, there were over 4 million new cases reported.
Industry Growth Insights published a new data on “Human Papillomavirus (HPV) Testing Market”. The research report is titled “Human Papillomavirus (HPV) Testing Market research by Types (Pap Smear Test, HPV DNA Test), By Applications (Diagnostic Centers, Hospitals, Clinic), By Players/Companies Roche, Agilent Technologies, Inc. , Becton, Dickinson and Company , Qiagen N.V. , Thermo Fisher Scientific Inc. , Abbott Laboratories , Hologic Inc. , Cepheid Inc. , Seegene Inc. , Takara Bio Inc. , DaAn Gene Co., Ltd. of Sun Yat-Sen University , Promega Corporation , Greiner Bio-One International GmbH (Greiner Holding AG) , Enzo Biochem Inc. , Norgen Biotek Corp. , DiagCor Bioscience Inc Ltd , Hybribio Limited , Zytovision GmbH , Arbor Vita Corporation , Medical & Biological Laboratories Co., Ltd , Fujirebio Diagnostics, Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Papillomavirus (HPV) Testing Market Research Report
By Type
Pap Smear Test, HPV DNA Test
By Application
Diagnostic Centers, Hospitals, Clinic
By Companies
Roche, Agilent Technologies, Inc. , Becton, Dickinson and Company , Qiagen N.V. , Thermo Fisher Scientific Inc. , Abbott Laboratories , Hologic Inc. , Cepheid Inc. , Seegene Inc. , Takara Bio Inc. , DaAn Gene Co., Ltd. of Sun Yat-Sen University , Promega Corporation , Greiner Bio-One International GmbH (Greiner Holding AG) , Enzo Biochem Inc. , Norgen Biotek Corp. , DiagCor Bioscience Inc Ltd , Hybribio Limited , Zytovision GmbH , Arbor Vita Corporation , Medical & Biological Laboratories Co., Ltd , Fujirebio Diagnostics, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
 Testing Industry Outlook.svg)
Global Human Papillomavirus (HPV) Testing Market Report Segments:
The global Human Papillomavirus (HPV) Testing market is segmented on the basis of:
Types
Pap Smear Test, HPV DNA Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Centers, Hospitals, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Agilent Technologies, Inc.Â
- Becton, Dickinson and CompanyÂ
- Qiagen N.V.Â
- Thermo Fisher Scientific Inc.Â
- Abbott LaboratoriesÂ
- Hologic Inc.Â
- Cepheid Inc.Â
- Seegene Inc.Â
- Takara Bio Inc.Â
- DaAn Gene Co., Ltd. of Sun Yat-Sen UniversityÂ
- Promega CorporationÂ
- Greiner Bio-One International GmbH (Greiner Holding AG)Â
- Enzo Biochem Inc.Â
- Norgen Biotek Corp.Â
- DiagCor Bioscience Inc LtdÂ
- Hybribio LimitedÂ
- Zytovision GmbHÂ
- Arbor Vita CorporationÂ
- Medical & Biological Laboratories Co., LtdÂ
- Fujirebio Diagnostics, Inc.
 Testing Market Overview.svg)
Highlights of The Human Papillomavirus (HPV) Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pap Smear Test
- HPV DNA Test
- By Application:
- Diagnostic Centers
- Hospitals
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Papillomavirus (HPV) Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Testing Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HPV testing is a procedure that can be used to determine if someone has the HPV virus. This virus can cause cervical cancer in women, and other types of cancers in both men and women. HPV testing can also help identify other types of infections that may be caused by the HPV virus.
Some of the key players operating in the human papillomavirus (hpv) testing market are Roche, Agilent Technologies, Inc.‚Â , Becton, Dickinson and Company‚Â , Qiagen N.V.‚Â , Thermo Fisher Scientific Inc.‚Â , Abbott Laboratories‚Â , Hologic Inc.‚Â , Cepheid Inc.‚Â , Seegene Inc.‚Â , Takara Bio Inc.‚Â , DaAn Gene Co., Ltd. of Sun Yat-Sen University‚Â , Promega Corporation‚Â , Greiner Bio-One International GmbH (Greiner Holding AG)‚Â , Enzo Biochem Inc.‚Â , Norgen Biotek Corp.‚Â , DiagCor Bioscience Inc Ltd‚Â , Hybribio Limited‚Â , Zytovision GmbH‚Â , Arbor Vita Corporation‚Â , Medical & Biological Laboratories Co., Ltd‚Â , Fujirebio Diagnostics, Inc..
The human papillomavirus (hpv) testing market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Human Papillomavirus (HPV) Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Human Papillomavirus (HPV) Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Human Papillomavirus (HPV) Testing Market - Supply Chain
4.5. Global Human Papillomavirus (HPV) Testing Market Forecast
4.5.1. Human Papillomavirus (HPV) Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Human Papillomavirus (HPV) Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Human Papillomavirus (HPV) Testing Market Absolute $ Opportunity
5. Global Human Papillomavirus (HPV) Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Type
5.3.1. Pap Smear Test
5.3.2. HPV DNA Test
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Human Papillomavirus (HPV) Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Application
6.3.1. Diagnostic Centers
6.3.2. Hospitals
6.3.3. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Human Papillomavirus (HPV) Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Human Papillomavirus (HPV) Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Human Papillomavirus (HPV) Testing Demand Share Forecast, 2019-2026
9. North America Human Papillomavirus (HPV) Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Application
9.4.1. Diagnostic Centers
9.4.2. Hospitals
9.4.3. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Type
9.7.1. Pap Smear Test
9.7.2. HPV DNA Test
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Human Papillomavirus (HPV) Testing Demand Share Forecast, 2019-2026
10. Latin America Human Papillomavirus (HPV) Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Application
10.4.1. Diagnostic Centers
10.4.2. Hospitals
10.4.3. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Type
10.7.1. Pap Smear Test
10.7.2. HPV DNA Test
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Human Papillomavirus (HPV) Testing Demand Share Forecast, 2019-2026
11. Europe Human Papillomavirus (HPV) Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Application
11.4.1. Diagnostic Centers
11.4.2. Hospitals
11.4.3. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Type
11.7.1. Pap Smear Test
11.7.2. HPV DNA Test
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractieness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Human Papillomavirus (HPV) Testing Demand Share, 2019-2026
12. Asia Pacific Human Papillomavirus (HPV) Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Application
12.4.1. Diagnostic Centers
12.4.2. Hospitals
12.4.3. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Type
12.7.1. Pap Smear Test
12.7.2. HPV DNA Test
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Human Papillomavirus (HPV) Testing Demand Share, 2019-2026
13. Middle East & Africa Human Papillomavirus (HPV) Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Application
13.4.1. Diagnostic Centers
13.4.2. Hospitals
13.4.3. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size and Volume Forecast by Type
13.7.1. Pap Smear Test
13.7.2. HPV DNA Test
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Human Papillomavirus (HPV) Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Human Papillomavirus (HPV) Testing Market: Market Share Analysis
14.2. Human Papillomavirus (HPV) Testing Distributors and Customers
14.3. Human Papillomavirus (HPV) Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Agilent Technologies, Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Becton, Dickinson and Company
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Qiagen N.V.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Thermo Fisher Scientific Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Abbott Laboratories
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hologic Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cepheid Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Seegene Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Takara Bio Inc.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. DaAn Gene Co., Ltd. of Sun Yat-Sen University
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Promega Corporation
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Greiner Bio-One International GmbH (Greiner Holding AG)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Enzo Biochem Inc.
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Norgen Biotek Corp.
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. DiagCor Bioscience Inc Ltd
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Hybribio Limited
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Zytovision GmbH
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Arbor Vita Corporation
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Medical & Biological Laboratories Co., Ltd
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
